Skip to content ↓

Jazz orchestra plans two performances

"Aardvark stands up for what's hale, hearty and eclectic," wrote CD Review, and proof of that lies in two upcoming presentations by Mark Harvey, lecturer in music, and his Aardvark Jazz Orchestra.

The group will perform a live concert of new works by Mr. Harvey on Sunday, April 16 at 8pm in Kresge Auditorium and a recorded concert of Duke Ellington compositions on Sunday, April 23 at 10pm on WGBH-FM (89.7 FM).

The April 16 concert will feature exploratory works by Mr. Harvey, including the world premieres of a suite for five trumpets, Gabriel's Choir, and a new extended piece for jazz orchestra.

The April 23 "Jazz from Studio Four" broadcast will air Aardvark's "Ellington Tribute Concert," recorded in April 1999 for Duke Ellington's 100th birthday. This concert featured performances by Aardvark, the MIT Chamber Choir, Ashmont's All Saints Episcopal Church Choir, Senior Lecturer Pamela Wood, Assistant Professor Thomas DeFrantz and Associate Dean Ayida Mthembu.

Aardvark has concertized widely in the Boston area and beyond with appearances at First Night, the Museum of Fine Arts, Wellesley College, Jacob's Pillow Dance Festival and the University of Maine at Augusta, among others. The band's four CD recordings have been enthusiastically received by the public and jazz press.

A version of this article appeared in MIT Tech Talk on April 12, 2000.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story